PolyCore Therapeutics

company

About

PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.

  • 11 - 50

Details

Last Funding Type
Seed
Industries
Health Care,Professional Services,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

PolyCore Therapeutics’ experienced team of scientists and life sciences professionals is dedicated to developing breakthrough treatments for CNS Diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.50M
PolyCore Therapeutics has raised a total of $1.50M in funding over 2 rounds. Their latest funding was raised on Apr 11, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 11, 2022 Seed 1 Xontogeny Detail
Aug 20, 2020 Grant $1.50M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
2
2
PolyCore Therapeutics is funded by 2 investors. Xontogeny and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
Xontogeny Yes Seed
National Institutes of Health Yes Grant